Periodical (Journal)

  1. PSIthority
  2. Library
  3. Periodicals
ISSN  :   0955-8810 ( Print )   |   1473-5849 ( Online )   Active

Behavioural Pharmacology

Aim & Scope
​​​​​​​​Behavioural Pharmacology publishes original research reports in diverse areas, ranging from ethopharmacology to the pharmacology of schedule-controlled operant behaviour, provided that their primary focus is behavioural. Topics include drug, chemical, and hormonal effects on behaviour, the neurochemical mechanisms underlying behaviour, and behavioural methods for the study of drug action. Both animal and human studies are published. Studies reporting neurochemical data have a predominantly behavioural focus, and human studies do not consist exclusively of clinical trials or case reports. Submitted articles undergo a preliminary review by the editor. Some articles may be returned to authors without further consideration. Those being considered for publication will undergo further assessment and peer-review by the editors and those invited to do so from a reviewer pool. Preference is given to studies that demonstrate and develop the potential of behavioural methods, and to papers reporting findings of direct relevance to clinical problems. [1]

Go to Website

2021
12 RESULTS in 114 msec
2021-02-15
Activation of L-type calcium channels and attenuation of oxidative stress are involved in the improving effect of methyl jasmonate on learning and memory and its anxiolytic property in rats.

T Hemati , M Abbasnejad , M Mollashahi , ... , A Shahraki

Behavioural Pharmacology , 2021

 
0 0
2021-02-15
Valproate selectively suppresses adolescent anabolic/androgenic steroid-induced aggressive behavior: implications for a role of hypothalamic γ-aminobutyric acid neural signaling.

TJ Lee , AF Zanello , TR Morrison , ... , RH Melloni

Behavioural Pharmacology , 2021

 
0 0
2021-02-15
Behavioral pharmacology of five novel synthetic cannabinoids.

MB Gatch , A Tourigny , RA Shetty , MJ Forster

Behavioural Pharmacology , 2021

 
0 0
2021-02-15
Tetracyclines, a promise for neuropsychiatric disorders: from adjunctive therapy to the discovery of new targets for rational drug design in psychiatry.

AJM Chaves Filho , M Mottin , MV Soares , ... , DS Macedo

Behavioural Pharmacology , 2021

 
0 0
2021-02-15
The selective 5-HT2A receptor agonist 25CN-NBOH does not affect reversal learning in mice.

AU Odland , JL Kristensen , JT Andreasen

Behavioural Pharmacology , 2021

 
0 0
2021-02-15
Subanesthetic ketamine with an AMPAkine attenuates motor impulsivity in rats.

BD Davis-Reyes , AE Smith , J Xu , ... , NC Anastasio

Behavioural Pharmacology , 2021

 
0 0
2021-02-15
Acute intrathecal administration of quipazine elicits air-stepping behavior.

HE Swann-Thomsen , DD Viall , MR Brumley

Behavioural Pharmacology , 2021

 
0 0
2021-02-15
Effects of 5-HT2A receptor agonist 2,5-dimethoxy-4-iodoamphetamine on alcohol consumption in Long-Evans rats.

MD Berquist , WE Fantegrossi

Behavioural Pharmacology , 2021

 
0 0
2021-02-08
The endocannabinoid system and drug-associated contextual memories.

L Asth , AC Santos , FA Moreira

Behavioural Pharmacology , 2021

 
0 0
2021-02-08
Discriminative stimulus effects of 3,4-methylenedioxypyrovalerone (MDPV) and structurally related synthetic cathinones.

RW Seaman , MR Doyle , A Sulima , ... , GT Collins

Behavioural Pharmacology , 2021

 
0 0